Back to search

Democritus University of Thrace (DUTH)

Biological and immunological activities of probiotic microorganisms in models of inflammation and cancer

Abstract

dc:description

Disorders of the gastrointestinal track, such as inflammatory bowel disease and colorectal cancer, are a substantial health hazard with high incidence and fatality rate. There is an association between the two, since patients suffering from inflammatory bowel disease have a higher risk of developing cancer, arising from chronic inflammation. Although the cause of the disease is not fully understood, exposure of susceptible individuals to environmental factors, such as the westernized diet, smoking, low physical activity and obesity, plays a crucial role. The prevalence of inflammatory disorders is one of the reasons that colorectal cancer incidence rate has spiked in the last decades, and although the mortality rate has been significantly reduced, cancer-related mortality worldwide has increased. In recent years intestinal microbiota have been identified as an important aspect involved in the emergence and progression of inflammatory bowel disease and colorectal cancer. The human microbiota comprises from trillion of bacteria, most of them in a commensal relationship with the host. However, disruption of the intestinal homeostasis can lead to dysbiosis and expansion of pathogenic microorganism that negatively affect the developmentof inflammatory conditions and neoplasia as well as response to therapeutic intervention against these disorders. Probiotic bacteria are defined as "live microorganisms that when administered in adequate amounts, confer a health benefit on the host". They have been shown to not only regulate the intestinal micro flora promoting homeostasis, but also prevent and ameliorate the course of digestive disorders, through a variety of ways. In this study we used the characterized probiotic strain Lactobacillus casei ATCC393 in various in vitro and in vivo models of inflammation and cancer in order to investigate its beneficial effects and the mechanisms implicated in them. Treatment of LPS-stimulated RAW 264.7 cells with the probiotic did not reduce their inflammatory potential, as expression of inflammation-related genes was not reduced. On the other hand, oraladministration of the microorganism ameliorated symptoms of DSS-induced colitis in BALB/c mice. Histological examination of the colon revealed lesions of milder severity and extent in the animals that had received lactobacilli. In addition, consumption of the probiotic beneficially modulated inflammatory cytokines in the large intestine reducing expression of IL-1β, IL-6 and TNF-α, and altered the ratio of infiltrated immune cells in the ulcerative lesions in favour of regulatory T lymphocytes with decreased numbers of neutrophils being present. Overall, L. casei promoted the progression of the inflammatory response into the process of healing and restoration of mucosal dysplasia. Next we examined the growth inhibitory activity of L. casei in colon cancer cells. Treatment with the microorganism induced a time- and concentration-dependent inhibitory effect on the viability of CT26 and HT29 cells, as did to a lesser extent cell-free supernatants of L. caseicultures. Incubation with live lactobacilli induced apoptosis of cancer cells, evident by the activation of the major effector caspase 3 and cleavage of PARP1. In addition, alterations in the expression and activity of various apoptosis- and proliferation-related proteins in favour of apoptosis was detected in HT29 cells, including down-regulation of survivin and phosphorylation of HSP27 and Akt, while simultaneously an increased phosphorylation of Chk2, p38 and p53 was observed. Immunogenic signalling, able to elicit adaptive immune responses against dying cell-derived antigens was noted, with the release of HMGB1 from the nucleus and the exposure of calreticulin on the plasma membrane of cancer cells. Administration of L. casei in a syngeneic colon adenocarcinoma model resulted in a significant tumor inhibitory effect, as tumor volume of treated animals was reduced by approximately 60%. Examination of the intestinal microbiota revealed alterations mostly concerning less abundant microorganisms that could be related to the suppression of tumor overgrowth. More prominent was the immunomodulatory effect of lactobacilli consumption, as potent Th1 and cytotoxic T cell responses were detected. The number of cytotoxic T cells was increased and production of IFN-γ was elevated in the tumor and systemically. IL-12 and IL-1β were also up-regulated in the tumor of treated animals, as were many chemokinesresponsible for immune cell trafficking and infiltration in the tumor; and primarily ligands of the receptors CCR5 and CXCR3 such as CCL3, CCL4, CCL5, CXCL9, CXCL10 and CXCL11. Accumulation of CD8+T lymphocytes in the tumor was observed (infiltration) and cytotoxicity against tumor cells was increased in lactobacilli-fed mice as evidenced by the elevation of caspase 3 and PARP-1 cleavage in cells of the tumor tissue. These data support that oral administration of Lactobacillus casei plays a significant role in immune function, inducing Th1 immune responses, indicated by the up-regulation in IFN-γ and IL-12 production, as well as augmented CD8+T lymphocyte infiltration in the tumor, resulting in suppression of tumor growth. Overall, our data show that consumption of the probiotic Lactobacillus casei has beneficial protective effects in preclinical experimental models of intestinal inflammation and colon cancer. Further investigations are needed to better understand the exact role of L. casei in immune function and diseases, especially in the initial stages of inflammation-related neoplasia, either directly or by modulation of the overall intestinal community. Examination of possible synergistic effects with existing chemotherapeutic and immunotherapeutictreatments is a promising field and could result in the utilization of cocktails with beneficial bacteria as immunoadjuvant agents in future therapeutic regimens.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Aindelis, Georgios
  • Αϊνδελής, Γεώργιος

Subjects

dc:subject × 13

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47317

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Aindelis, Georgios; Αϊνδελής, Γεώργιος. Biological and immunological activities of probiotic microorganisms in models of inflammation and cancer. Democritus University of Thrace (DUTH), 2020. http://hdl.handle.net/10442/hedi/47317